Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03087357 · ClinicalTrials.gov registry record
VAlidation of a Lower Cost aneUploidy scrEen
A clinical trial, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- 2,443
- Enrollment target
NCT03087357 is a clinical trial that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 2,443 participants.
The verdict
NCT03087357 has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- 2,443 participants
- Enrollment target
Study Summary
This study will document the detection rate and false positive rate as well as failure rate of a new prenatal screening approach ('Smart NIPT') as described at www.vanadisdx.com and implemented in an academic laboratory with limited molecular testing experience. Testing will be performed on samples from a general risk pregnancy population, with additional high-risk cases added to improve confidence in the detection rate. Additional characteristics of this non-NGS test such as turn-around time, costs (equipment, training, per test), results reporting, fetal sex, fetal fraction, and quality measures will also be examined.
Interventions
- OTHER SmartNIPT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,443 participants |
| Start Date | 2017-10-10 |
| Est. Completion | 2020-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03087357
The ClinicalTrials.gov registry entry for NCT03087357 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,443 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Women and Infants Hospital of Rhode Island, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SmartNIPT is the first listed.
NCT03087357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03087357 about?
NCT03087357 is a clinical study titled "VAlidation of a Lower Cost aneUploidy scrEen". This study will document the detection rate and false positive rate as well as failure rate of a new prenatal screening approach ('Smart NIPT') as described at www.vanadisdx.com and implemented in an academic laboratory with limited molecular testing experience. Testing will be performed on samples ...
What is the current status of trial NCT03087357?
This trial is currently completed. The enrollment target is 2,443 participants. The study started on 2017-10-10. Estimated completion is 2020-10-01.
What interventions are being tested in trial NCT03087357?
The interventions under investigation include: SmartNIPT (OTHER).
Who is sponsoring clinical trial NCT03087357?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.